Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 40 of the 40 references it cites were found in a registry or an index.

The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis

Abstract

Background: Psychostimulants are frequently prescribed off-label for adults with major depressive disorder or bipolar disorder. The frequent and increasing usage of stimulants in mood disorders warrants a careful appraisal of the efficacy of this class of agents. Herein, we aim to estimate the efficacy of psychostimulants in adults with unipolar or bipolar depression. Methods: The PubMed/Medline database was searched from inception to January 16, 2016 for randomized, placebo-controlled clinical trials investigating the antidepressant efficacy of psychostimulants in the treatment of adults with unipolar or bipolar depression. Results: Psychostimulants were associated with statistically significant improvement in depressive symptoms in major depressive disorder (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.13–1.78; P = 0.003) and bipolar disorder (OR, 1.42; 95% CI, 1.13–1.78; P = 0.003). Efficacy outcomes differed across the psychostimulants evaluated as a function of response rates: ar/modafinil (OR, 1.47; 95% CI, 1.20–1.81; P = 0.0002); dextroamphetamine (OR, 7.11; 95% CI, 1.09–46.44; P = 0.04); lisdexamfetamine dimesylate (OR, 1.21; 95% CI, 0.94–1.56; P = ns); methylphenidate (OR, 1.49; 95% CI, 0.88–2.54; P = ns). Efficacy outcomes also differed between agents used as adjunctive therapy (OR, 1.39; 95% CI, 1.19–1.64) or monotherapy (OR, 2.25; 95% CI, 0.67–7.52). Conclusions: Psychostimulants are insufficiently studied as adjunctive or monotherapy in adults with mood disorders. Most published studies have significant methodological limitations (eg, heterogeneous samples, dependent measures, type/dose of agent). In addition to improvements in methodological factors, a testable hypothesis is that psychostimulants may be more appropriately tested in select domains of psychopathology (eg, cognitive emotional processing), rather than as “broad-spectrum” antidepressants.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0000000000000723

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. 2008, Psychostimulants for depression, Cochrane Database Syst Rev, 2, CD006722

Cited by

See all 86

Metadata

Authors
McIntyre, R. S., Lee, Y., Zhou, A. J., Rosenblat, J. D., Peters, E. M., Lam, R. W., Kennedy, S. H., Rong, C., & Jerrell, J. M.
Affiliations
  • University Health Network (CA)
  • University of Saskatchewan (CA)
  • University of British Columbia (CA)
Corresponding author
  • McIntyre, Roger S.
  • Lee, Yena
  • Zhou, Aileen J.
  • Rosenblat, Joshua D.
  • Kennedy, Sidney H.
  • Rong, Carola
  • Jerrell, Jeanette M.
Venue
Journal of Clinical Psychopharmacology
Published
2017-08
Volume
37
Issue
4
Pages
412-418
ISSN
  • 0271-0749 (ISSN-L)
  • 1533-712X
OpenAlex
W2622834257
Cited by
75
References
40
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 7 · 2021: 13 · 2020: 10 · 2019: 11 · 2018: 7 · 2017: 2
FWCI
1.04
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Keywords
psychostimulants, major depressive disorder, bipolar depression, antidepressant efficacy, modafinil, d-amphetamine, lisdexamfetamine, methylphenidate, adjunctive therapy, monotherapy, methodological limitations, mood disorders, adults, response rate, depressive symptoms
MeSH terms
Modafinil, Central Nervous System Stimulants, Benzhydryl Compounds, Major Depressive Disorder, Dextroamphetamine, Humans, Methylphenidate, Psychotropic Drugs, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1097/jcp.0000000000000723
The paper
McIntyre, R. S., Lee, Y., Zhou, A. J., Rosenblat, J. D., Peters, E. M., Lam, R. W., Kennedy, S. H., Rong, C., & Jerrell, J. M. (2017). The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000723

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.